Clinical Challenges: Use of Adjuvant Immunotherapy in RCC
MedPage Today,
Clinical Challenges > ASCO: Renal Cell Carcinoma More data awaited, but until then, decisions should be made on case-by-case…
Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial
Overview of attention for article published in European Urology, January 2021
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (95th percentile)
-
High Attention Score compared to outputs of the same age and source (89th percentile)
Mentioned by
- news
- 2 news outlets
- 55 X users
- 1 Facebook page
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 56 Mendeley
